Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patientsQingtao Ni(Nantong University), Heidi Schwarzenbach(University Medical Center Hamburg-Eppendorf)Scientific ReportsAugust 22, 201810.1038/s41598-018-31108-yCited by 82SaveCiteExport RISWatch citationsRelated PapersExosomal micro<scp>RNA</scp>s as tumor markers in epithelial ovarian cancer|Molecular Oncology|2018|183Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors|PLoS ONE|2012|70Radiation prevents tumor progression by inhibiting the miR‑93‑5p/EphA4/NF‑κB pathway in triple‑negative breast cancer|Oncology Reports|2023|7